TY - JOUR AB - The development and regulation of malignant self-renewal remains an unresolved issue. Here, we provide biochemical, genetic, and functional evidence that dynamics in ribosomal RNA (rRNA) 2'-O-methylation regulate leukemia stem cell (LSC) activity in vivo. A comprehensive analysis of the rRNA 2'-O-methylation landscape of 94 acute myeloid leukemia (AML) patients revealed dynamic 2'-O-methylation specifically at exterior sites of ribosomes. rRNA 2'-O-methylation pattern is closely associated with AML development stage and LSC gene expression signature. Forced expression of 2'-O-methyltransferase FBL induced an AML stem cell phenotype and enabled engraftment of non-LSC leukemia cells in NSG mice. Enhanced 2'-O-methylation redirected the ribosome translation program towards amino acid transporter mRNAs enriched in optimal codons and subsequently increased intracellular amino acid levels. Methylation at the single site 18S-guanosine 1447 was instrumental for LSC activity. Collectively, our work demonstrates that dynamic 2'-O-Me at specific sites on ribosomal RNAs shifts translational preferences and controls AML-LSC self-renewal. AU - Zhou, F.* AU - Aroua, N.* AU - Liu, Y.* AU - Rohde, C.* AU - Cheng, J.* AU - Wirth, A.-K. AU - Fijalkowska, D.* AU - Göllner, S.* AU - Lotze, M.T.* AU - Yun, H.* AU - Yu, X.* AU - Pabst, C.* AU - Sauer, T.* AU - Oellerich, T.* AU - Serve, H.* AU - Röllig, C.* AU - Bornhäuser, M.* AU - Thiede, C.* AU - Baldus, C.* AU - Frye, M.* AU - Raffel, S.* AU - Krijgsveld, J.* AU - Jeremias, I. AU - Beckmann, R.* AU - Trumpp, A.* AU - Müller-Tidow, C.* C1 - 66477 C2 - 52829 CY - 615 Chestnut St, 17th Floor, Philadelphia, Pa 19106-4404 Usa SP - 1–17 TI - A dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia. JO - Cancer Discov. VL - 13 IS - 2 PB - Amer Assoc Cancer Research PY - 2023 SN - 2159-8274 ER - TY - JOUR AB - Cancer-associated inflammation is a molecular key feature in pancreatic ductal adenocarcinoma. Oncogenic KRAS in conjunction with persistent inflammation is known to accelerate carcinogenesis, although the underlying mechanisms remain poorly understood. Here, we outline a novel pathway whereby the transcription factors NFATc1 and STAT3 cooperate in pancreatic epithelial cells to promote Kras G12D - driven carcinogenesis. NFATc1 activation is induced by inflammation and itself accelerates inflammation-induced carcinogenesis in KrasG12D mice, whereas genetic or pharmacologic ablation of NFATc1 attenuates this effect. Mechanistically, NFATc1 complexes with STAT3 for enhancer-promoter communications at jointly regulated genes involved in oncogenesis, for example, Cyclin, EGFR and WNT family members. The NFATc1-STAT3 cooperativity is operative in pancreatitis-mediated carcinogenesis as well as in established human pancreatic cancer. Together, these studies unravel new mechanisms of inflammatory-driven pancreatic carcinogenesis and suggest beneficial effects of chemopreventive strategies using drugs that are currently available for targeting these factors in clinical trials. SIGNIFICANCE: Our study points to the existence of an oncogenic NFATc1-STAT3 cooperativity that mechanistically links inflammation with pancreatic cancer initiation and progression. Because NFATc1-STAT3 nucleoprotein complexes control the expression of gene networks at the intersection of inflammation and cancer, our study has signifi cant relevance for potentially managing pancreatic cancer and other inflammatory-driven malignancies. AU - Baumgart, S.* AU - Chen, N.* AU - Siveke, J.T.* AU - König, A.O.* AU - Zhang, J.* AU - Singh, S.K.* AU - Wolf, E.* AU - Bartkuhn, M.* AU - Esposito, I. AU - Heßmann, E.* AU - Reinecke, J.* AU - Nikorowitsch, J.* AU - Brunner, M.* AU - Singh, G.P.* AU - Fernández-Zapico, M.E.* AU - Smyrk, T.C.* AU - Bamlet, W.R.* AU - Eilers, M.* AU - Neeße, A.* AU - Gress, T.M.* AU - Billadeau, D.D.* AU - Tuveson, D.A.* AU - Urrutia, R.A.* AU - Ellenrieder, V.* C1 - 32704 C2 - 35583 SP - 688-701 TI - Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. JO - Cancer Discov. VL - 4 IS - 6 PY - 2014 SN - 2159-8274 ER -